Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease: time for a high-definition picture?

Lucilla Piccari; Roberto J. Bernardo; Diego Rodríguez-Chiaradía; Patrizio Vitulo; S. John Wort; Sandeep Sahay

doi:10.1177/20458940211018074

Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease: time for a high-definition picture?

Lucilla Piccari, Roberto J. Bernardo, Diego Rodríguez-Chiaradía, Patrizio Vitulo, S. John Wort, Sandeep Sahay

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Journal	Pulmonary Circulation
Volume	11
Issue number	2
DOIs	https://doi.org/10.1177/20458940211018074
State	E-pub ahead of print - May 12 2021

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

Access to Document

10.1177/20458940211018074

Cite this

@article{b44b1701c38f4ebba8857d83f07e26e1,

title = "Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease: time for a high-definition picture?",

author = "Lucilla Piccari and Bernardo, {Roberto J.} and Diego Rodr{\'i}guez-Chiarad{\'i}a and Patrizio Vitulo and Wort, {S. John} and Sandeep Sahay",

note = "Funding Information: S.S.: Consultancy fees from Janssen Pharmaceutical Companies of Johnson & Johnson, United Therapeutics, Bayer Pharmaceuticals; research/grant support from Chest Foundation (ILD research grant); Scientific medical advisor fees for United Therapeutics, Altavant Sciences, and Liquidia; and Speaker{\textquoteright}s bureau fees from Janssen Pharmaceutical Companies of Johnson & Johnson, Bayer, and United Therapeutics. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.",

year = "2021",

month = may,

day = "12",

doi = "10.1177/20458940211018074",

language = "English (US)",

volume = "11",

journal = "Pulmonary Circulation",

issn = "2045-8932",

publisher = "Wiley",

number = "2",

}

TY - JOUR

T1 - Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease

T2 - time for a high-definition picture?

AU - Piccari, Lucilla

AU - Bernardo, Roberto J.

AU - Rodríguez-Chiaradía, Diego

AU - Vitulo, Patrizio

AU - Wort, S. John

AU - Sahay, Sandeep

N1 - Funding Information: S.S.: Consultancy fees from Janssen Pharmaceutical Companies of Johnson & Johnson, United Therapeutics, Bayer Pharmaceuticals; research/grant support from Chest Foundation (ILD research grant); Scientific medical advisor fees for United Therapeutics, Altavant Sciences, and Liquidia; and Speaker’s bureau fees from Janssen Pharmaceutical Companies of Johnson & Johnson, Bayer, and United Therapeutics. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.

PY - 2021/5/12

Y1 - 2021/5/12

UR - http://www.scopus.com/inward/record.url?scp=85107019364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85107019364&partnerID=8YFLogxK

U2 - 10.1177/20458940211018074

DO - 10.1177/20458940211018074

M3 - Letter

AN - SCOPUS:85107019364

SN - 2045-8932

VL - 11

JO - Pulmonary Circulation

JF - Pulmonary Circulation

IS - 2

ER -

Pulmonary vasodilator treatment in pulmonary hypertension due to left heart or lung disease: time for a high-definition picture?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this